Angiogenesis Modulators Market Report

1 Report Overview

• 1.1 Product Definition and Scope

• 1.2 PEST (Political, Economic, Social and Technological) Analysis of Angiogenesis Modulators Market

• 1.3 Market Segment by Type

• 1.3.1 Japan Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Inhibitors from 2014 to 2026

• 1.3.2 Japan Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Stimulators from 2014 to 2026

• 1.3.3 Japan Angiogenesis Modulators Market Size and Growth Rate of Angiogenin from 2014 to 2026

• 1.3.4 Japan Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

• 1.4 Market Segment by Application

• 1.4.1 Japan Angiogenesis Modulators Market Size and Growth Rate of Cancer from 2014 to 2026

• 1.4.2 Japan Angiogenesis Modulators Market Size and Growth Rate of Cardiology from 2014 to 2026

• 1.4.3 Japan Angiogenesis Modulators Market Size and Growth Rate of Ophthalmology from 2014 to 2026

• 1.4.4 Japan Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

• 1.5 Market Segment by Regions

• 1.5.1 Hokkaido Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.2 Tohoku Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.3 Kanto Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.4 Chubu Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.5 Kinki Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.6 Chugoku Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.7 Shikoku Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.8 Kyushu Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

• 2.1 Market Trends and Dynamics

• 2.1.1 Market Challenges and Restraints

• 2.1.2 Market Opportunities and Potentials

• 2.1.3 Mergers and Acquisitions

• 2.2 Competitive Landscape Analysis

• 2.2.1 Industrial Concentration Analysis

• 2.2.2 Porter's Five Forces Analysis of the Industry

• 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Angiogenesis Modulators Market by Types

• 3.1 Products Development Trends of Different Types

• 3.2 Commercial Products Types of Major Vendors

• 3.3 Competitive Landscape Analysis of Different Types

• 3.4 Market Size of Angiogenesis Modulators by Major Types

• 3.4.1 Market Size and Growth Rate of Angiogenesis Inhibitors

• 3.4.2 Market Size and Growth Rate of Angiogenesis Stimulators

• 3.4.3 Market Size and Growth Rate of Angiogenin

• 3.4.4 Market Size and Growth Rate of Others

4 Segmentation of Angiogenesis Modulators Market by End-Users

• 4.1 Downstream Client Analysis by End-Users

• 4.2 Competitive Landscape Analysis of Different End-Users

• 4.3 Market Potential Analysis of Different End-Users

• 4.4 Market Size of Angiogenesis Modulators by Major End-Users

• 4.4.1 Market Size and Growth Rate of Angiogenesis Modulators in Cancer

• 4.4.2 Market Size and Growth Rate of Angiogenesis Modulators in Cardiology

• 4.4.3 Market Size and Growth Rate of Angiogenesis Modulators in Ophthalmology

• 4.4.4 Market Size and Growth Rate of Angiogenesis Modulators in Others

5 Market Analysis by Regions

• 5.1 Japan Angiogenesis Modulators Production Analysis by Regions

• 5.2 Japan Angiogenesis Modulators Consumption Analysis by Regions

6 Hokkaido Angiogenesis Modulators Landscape Analysis

• 6.1 Hokkaido Angiogenesis Modulators Landscape Analysis by Major Types

• 6.2 Hokkaido Angiogenesis Modulators Landscape Analysis by Major End-Users

7 Tohoku Angiogenesis Modulators Landscape Analysis

• 7.1 Tohoku Angiogenesis Modulators Landscape Analysis by Major Types

• 7.2 Tohoku Angiogenesis Modulators Landscape Analysis by Major End-Users

8 Kanto Angiogenesis Modulators Landscape Analysis

• 8.1 Kanto Angiogenesis Modulators Landscape Analysis by Major Types

• 8.2 Kanto Angiogenesis Modulators Landscape Analysis by Major End-Users

9 Chubu Angiogenesis Modulators Landscape Analysis

• 9.1 Chubu Angiogenesis Modulators Landscape Analysis by Major Types

• 9.2 Chubu Angiogenesis Modulators Landscape Analysis by Major End-Users

10 Kinki Angiogenesis Modulators Landscape Analysis

• 10.1 Kinki Angiogenesis Modulators Landscape Analysis by Major Types

• 10.2 Kinki Angiogenesis Modulators Landscape Analysis by Major End-Users

11 Chugoku Angiogenesis Modulators Landscape Analysis

• 11.1 Chugoku Angiogenesis Modulators Landscape Analysis by Major Types

• 11.2 Chugoku Angiogenesis Modulators Landscape Analysis by Major End-Users

12 Shikoku Angiogenesis Modulators Landscape Analysis

• 12.1 Shikoku Angiogenesis Modulators Landscape Analysis by Major Types

• 12.2 Shikoku Angiogenesis Modulators Landscape Analysis by Major End-Users

13 Kyushu Angiogenesis Modulators Landscape Analysis

• 13.1 Kyushu Angiogenesis Modulators Landscape Analysis by Major Types

• 13.2 Kyushu Angiogenesis Modulators Landscape Analysis by Major End-Users

14 Major Players Profiles

• 14.1 Chugai Pharmaceutical Co., Ltd.
  

• 14.1.1 Chugai Pharmaceutical Co., Ltd. Company Profile and Recent Development

• 14.1.2 Market Performance

• 14.1.3 Product and Service Introduction

• 14.2 Eye-Tech Inc
  

• 14.2.1 Eye-Tech Inc Company Profile and Recent Development

• 14.2.2 Market Performance

• 14.2.3 Product and Service Introduction

• 14.3 Genzyme Corporation.
  

• 14.3.1 Genzyme Corporation. Company Profile and Recent Development

• 14.3.2 Market Performance

• 14.3.3 Product and Service Introduction

• 14.4 Merck & Co., Inc.
  

• 14.4.1 Merck & Co., Inc. Company Profile and Recent Development

• 14.4.2 Market Performance

• 14.4.3 Product and Service Introduction

• 14.5 Amgen, Inc
  

• 14.5.1 Amgen, Inc Company Profile and Recent Development

• 14.5.2 Market Performance

• 14.5.3 Product and Service Introduction

• 14.6 GlaxoSmithKline plc
  

• 14.6.1 GlaxoSmithKline plc Company Profile and Recent Development

• 14.6.2 Market Performance

• 14.6.3 Product and Service Introduction

• 14.7 Imclone Systems, Inc.
  

• 14.7.1 Imclone Systems, Inc. Company Profile and Recent Development

• 14.7.2 Market Performance

• 14.7.3 Product and Service Introduction

• 14.8 Ångstrom Pharmaceuticals, Inc
  

• 14.8.1 Ångstrom Pharmaceuticals, Inc Company Profile and Recent Development

• 14.8.2 Market Performance

• 14.8.3 Product and Service Introduction

• 14.9 Progen Pharmaceuticals Ltd
  

• 14.9.1 Progen Pharmaceuticals Ltd Company Profile and Recent Development

• 14.9.2 Market Performance

• 14.9.3 Product and Service Introduction

• 14.10 Genvec, Inc
  

• 14.10.1 Genvec, Inc Company Profile and Recent Development

• 14.10.2 Market Performance

• 14.10.3 Product and Service Introduction

• 14.11 ThromboGenics, Inc
  

• 14.11.1 ThromboGenics, Inc Company Profile and Recent Development

• 14.11.2 Market Performance

• 14.11.3 Product and Service Introduction

• 14.12 Angiotech Pharmaceuticals, Inc
  

• 14.12.1 Angiotech Pharmaceuticals, Inc Company Profile and Recent Development

• 14.12.2 Market Performance

• 14.12.3 Product and Service Introduction

• 14.13 Aeterna Zentaris Inc.
  

• 14.13.1 Aeterna Zentaris Inc. Company Profile and Recent Development

• 14.13.2 Market Performance

• 14.13.3 Product and Service Introduction

• 14.14 Genentech, Inc.
  

• 14.14.1 Genentech, Inc. Company Profile and Recent Development

• 14.14.2 Market Performance

• 14.14.3 Product and Service Introduction

• 14.15 Entremed, Inc.
  

• 14.15.1 Entremed, Inc. Company Profile and Recent Development

• 14.15.2 Market Performance

• 14.15.3 Product and Service Introduction

• 14.16 Bayer Healthcare AG
  

• 14.16.1 Bayer Healthcare AG Company Profile and Recent Development

• 14.16.2 Market Performance

• 14.16.3 Product and Service Introduction

• 14.17 Abbott Laboratories.
  

• 14.17.1 Abbott Laboratories. Company Profile and Recent Development

• 14.17.2 Market Performance

• 14.17.3 Product and Service Introduction

• 14.18 FHoffmann-La Roche Ltd
  

• 14.18.1 FHoffmann-La Roche Ltd Company Profile and Recent Development

• 14.18.2 Market Performance

• 14.18.3 Product and Service Introduction

• 14.19 Eli Lilly and Company
  

• 14.19.1 Eli Lilly and Company Company Profile and Recent Development

• 14.19.2 Market Performance

• 14.19.3 Product and Service Introduction

• 14.20 OXiGENE, Inc.
  

• 14.20.1 OXiGENE, Inc. Company Profile and Recent Development

• 14.20.2 Market Performance

• 14.20.3 Product and Service Introduction

• 14.21 F.Hoffmann-La Roche Ltd
  

• 14.21.1 F.Hoffmann-La Roche Ltd Company Profile and Recent Development

• 14.21.2 Market Performance

• 14.21.3 Product and Service Introduction

• 14.22 Merck & Co, Inc
  

• 14.22.1 Merck & Co, Inc Company Profile and Recent Development

• 14.22.2 Market Performance

• 14.22.3 Product and Service Introduction

• 14.23 Silence Therapeutics plc
  

• 14.23.1 Silence Therapeutics plc Company Profile and Recent Development

• 14.23.2 Market Performance

• 14.23.3 Product and Service Introduction

• 14.24 Astrazeneca plc
  

• 14.24.1 Astrazeneca plc Company Profile and Recent Development

• 14.24.2 Market Performance

• 14.24.3 Product and Service Introduction

• 14.25 Chugai Pharmaceutical Co, Ltd
  

• 14.25.1 Chugai Pharmaceutical Co, Ltd Company Profile and Recent Development

• 14.25.2 Market Performance

• 14.25.3 Product and Service Introduction

• 14.26 Celgene Corporation.
  

• 14.26.1 Celgene Corporation. Company Profile and Recent Development

• 14.26.2 Market Performance

• 14.26.3 Product and Service Introduction

• 14.27 Antisoma plc
  

• 14.27.1 Antisoma plc Company Profile and Recent Development

• 14.27.2 Market Performance

• 14.27.3 Product and Service Introduction

• 14.28 Merck KGaA
  

• 14.28.1 Merck KGaA Company Profile and Recent Development

• 14.28.2 Market Performance

• 14.28.3 Product and Service Introduction

• 14.29 Alcon, Inc.
  

• 14.29.1 Alcon, Inc. Company Profile and Recent Development

• 14.29.2 Market Performance

• 14.29.3 Product and Service Introduction

The List of Tables and Figures (Totals 104 Figures and 123 Tables)

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Inhibitors from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Angiogenesis Stimulators from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Angiogenin from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

• Figure Market Share by Type in 2014

• Figure Market Share by Type in 2018

• Figure Market Share by Type in 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Cancer from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Cardiology from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Ophthalmology from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

• Figure Market Share by End-User in 2014

• Figure Market Share by End-User in 2018

• Figure Market Share by End-User in 2026

• Figure Hokkaido Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Tohoku Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kanto Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chubu Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kinki Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chugoku Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Shikoku Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kyushu Angiogenesis Modulators Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Development Trends and Industry Dynamics of Angiogenesis Modulators Industry

• Figure Market Challenges and Restraints

• Figure Market Opportunities and Potentials

• Table Mergers and Acquisition

• Figure Market Share of TOP 3 Players in 2018

• Figure Market Share of TOP 5 Players in 2018

• Figure Market Share of TOP 6 Players from 2014 to 2019

• Figure Porter's Five Forces Analysis

• Figure New Entrant SWOT Analysis

• Table Specifications of Different Types of Angiogenesis Modulators

• Figure Development Trends of Different Types

• Table Commercial Products Types of Major Vendors

• Figure Competitive Landscape Analysis of Different Types

• Table Consumption of Angiogenesis Modulators by Different Types from 2014 to 2026

• Table Consumption Share of Angiogenesis Modulators by Different Types from 2014 to 2026

• Figure Market Size and Growth Rate of Angiogenesis Inhibitors

• Figure Market Size and Growth Rate of Angiogenesis Stimulators

• Figure Market Size and Growth Rate of Angiogenin

• Figure Market Size and Growth Rate of Others

• Table Downstream Client Analysis by End-Users

• Figure Competitive Landscape Analysis of Different End-Users

• Table Market Potential Analysis of Different End-Users

• Table Consumption of Angiogenesis Modulators by Different End-Users from 2014 to 2026

• Table Consumption Share of Angiogenesis Modulators by Different End-Users from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Cancer from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Cardiology from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Ophthalmology from 2014 to 2026

• Figure Japan Angiogenesis Modulators Market Size and Growth Rate of Others from 2014 to 2026

• Table Japan Angiogenesis Modulators Production by Regions

• Table Japan Angiogenesis Modulators Production Share by Regions

• Figure Japan Angiogenesis Modulators Production Share by Regions in 2014

• Figure Japan Angiogenesis Modulators Production Share by Regions in 2018

• Figure Japan Angiogenesis Modulators Production Share by Regions in 2026

• Table Japan Angiogenesis Modulators Consumption by Regions

• Table Japan Angiogenesis Modulators Consumption Share by Regions

• Figure Japan Angiogenesis Modulators Consumption Share by Regions in 2014

• Figure Japan Angiogenesis Modulators Consumption Share by Regions in 2018

• Figure Japan Angiogenesis Modulators Consumption Share by Regions in 2026

• Table Hokkaido Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Hokkaido Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Hokkaido Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Hokkaido Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Hokkaido Angiogenesis Modulators Consumption Share by Types in 2026

• Table Hokkaido Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Hokkaido Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Hokkaido Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Hokkaido Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Hokkaido Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Tohoku Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Tohoku Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Tohoku Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Tohoku Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Tohoku Angiogenesis Modulators Consumption Share by Types in 2026

• Table Tohoku Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Tohoku Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Tohoku Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Tohoku Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Tohoku Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Kanto Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Kanto Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Kanto Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Kanto Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Kanto Angiogenesis Modulators Consumption Share by Types in 2026

• Table Kanto Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Kanto Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Kanto Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Kanto Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Kanto Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Chubu Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Chubu Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Chubu Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Chubu Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Chubu Angiogenesis Modulators Consumption Share by Types in 2026

• Table Chubu Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Chubu Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Chubu Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Chubu Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Chubu Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Kinki Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Kinki Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Kinki Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Kinki Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Kinki Angiogenesis Modulators Consumption Share by Types in 2026

• Table Kinki Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Kinki Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Kinki Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Kinki Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Kinki Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Chugoku Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Chugoku Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Chugoku Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Chugoku Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Chugoku Angiogenesis Modulators Consumption Share by Types in 2026

• Table Chugoku Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Chugoku Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Chugoku Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Chugoku Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Chugoku Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Shikoku Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Shikoku Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Shikoku Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Shikoku Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Shikoku Angiogenesis Modulators Consumption Share by Types in 2026

• Table Shikoku Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Shikoku Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Shikoku Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Shikoku Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Shikoku Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Kyushu Angiogenesis Modulators Consumption by Types from 2014 to 2026

• Table Kyushu Angiogenesis Modulators Consumption Share by Types from 2014 to 2026

• Figure Kyushu Angiogenesis Modulators Consumption Share by Types in 2014

• Figure Kyushu Angiogenesis Modulators Consumption Share by Types in 2018

• Figure Kyushu Angiogenesis Modulators Consumption Share by Types in 2026

• Table Kyushu Angiogenesis Modulators Consumption by End-Users from 2014 to 2026

• Table Kyushu Angiogenesis Modulators Consumption Share by End-Users from 2014 to 2026

• Figure Kyushu Angiogenesis Modulators Consumption Share by End-Users in 2014

• Figure Kyushu Angiogenesis Modulators Consumption Share by End-Users in 2018

• Figure Kyushu Angiogenesis Modulators Consumption Share by End-Users in 2026

• Table Company Profile and Development Status of Chugai Pharmaceutical Co., Ltd.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chugai Pharmaceutical Co., Ltd.

• Figure Sales and Growth Rate Analysis of Chugai Pharmaceutical Co., Ltd.

• Figure Revenue and Market Share Analysis of Chugai Pharmaceutical Co., Ltd.

• Table Product and Service Introduction of Chugai Pharmaceutical Co., Ltd.

• Table Company Profile and Development Status of Eye-Tech Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eye-Tech Inc

• Figure Sales and Growth Rate Analysis of Eye-Tech Inc

• Figure Revenue and Market Share Analysis of Eye-Tech Inc

• Table Product and Service Introduction of Eye-Tech Inc

• Table Company Profile and Development Status of Genzyme Corporation.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme Corporation.

• Figure Sales and Growth Rate Analysis of Genzyme Corporation.

• Figure Revenue and Market Share Analysis of Genzyme Corporation.

• Table Product and Service Introduction of Genzyme Corporation.

• Table Company Profile and Development Status of Merck & Co., Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co., Inc.

• Figure Sales and Growth Rate Analysis of Merck & Co., Inc.

• Figure Revenue and Market Share Analysis of Merck & Co., Inc.

• Table Product and Service Introduction of Merck & Co., Inc.

• Table Company Profile and Development Status of Amgen, Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen, Inc

• Figure Sales and Growth Rate Analysis of Amgen, Inc

• Figure Revenue and Market Share Analysis of Amgen, Inc

• Table Product and Service Introduction of Amgen, Inc

• Table Company Profile and Development Status of GlaxoSmithKline plc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

• Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

• Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

• Table Product and Service Introduction of GlaxoSmithKline plc

• Table Company Profile and Development Status of Imclone Systems, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Imclone Systems, Inc.

• Figure Sales and Growth Rate Analysis of Imclone Systems, Inc.

• Figure Revenue and Market Share Analysis of Imclone Systems, Inc.

• Table Product and Service Introduction of Imclone Systems, Inc.

• Table Company Profile and Development Status of Ångstrom Pharmaceuticals, Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ångstrom Pharmaceuticals, Inc

• Figure Sales and Growth Rate Analysis of Ångstrom Pharmaceuticals, Inc

• Figure Revenue and Market Share Analysis of Ångstrom Pharmaceuticals, Inc

• Table Product and Service Introduction of Ångstrom Pharmaceuticals, Inc

• Table Company Profile and Development Status of Progen Pharmaceuticals Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progen Pharmaceuticals Ltd

• Figure Sales and Growth Rate Analysis of Progen Pharmaceuticals Ltd

• Figure Revenue and Market Share Analysis of Progen Pharmaceuticals Ltd

• Table Product and Service Introduction of Progen Pharmaceuticals Ltd

• Table Company Profile and Development Status of Genvec, Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genvec, Inc

• Figure Sales and Growth Rate Analysis of Genvec, Inc

• Figure Revenue and Market Share Analysis of Genvec, Inc

• Table Product and Service Introduction of Genvec, Inc

• Table Company Profile and Development Status of ThromboGenics, Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of ThromboGenics, Inc

• Figure Sales and Growth Rate Analysis of ThromboGenics, Inc

• Figure Revenue and Market Share Analysis of ThromboGenics, Inc

• Table Product and Service Introduction of ThromboGenics, Inc

• Table Company Profile and Development Status of Angiotech Pharmaceuticals, Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Angiotech Pharmaceuticals, Inc

• Figure Sales and Growth Rate Analysis of Angiotech Pharmaceuticals, Inc

• Figure Revenue and Market Share Analysis of Angiotech Pharmaceuticals, Inc

• Table Product and Service Introduction of Angiotech Pharmaceuticals, Inc

• Table Company Profile and Development Status of Aeterna Zentaris Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aeterna Zentaris Inc.

• Figure Sales and Growth Rate Analysis of Aeterna Zentaris Inc.

• Figure Revenue and Market Share Analysis of Aeterna Zentaris Inc.

• Table Product and Service Introduction of Aeterna Zentaris Inc.

• Table Company Profile and Development Status of Genentech, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc.

• Figure Sales and Growth Rate Analysis of Genentech, Inc.

• Figure Revenue and Market Share Analysis of Genentech, Inc.

• Table Product and Service Introduction of Genentech, Inc.

• Table Company Profile and Development Status of Entremed, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Entremed, Inc.

• Figure Sales and Growth Rate Analysis of Entremed, Inc.

• Figure Revenue and Market Share Analysis of Entremed, Inc.

• Table Product and Service Introduction of Entremed, Inc.

• Table Company Profile and Development Status of Bayer Healthcare AG

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare AG

• Figure Sales and Growth Rate Analysis of Bayer Healthcare AG

• Figure Revenue and Market Share Analysis of Bayer Healthcare AG

• Table Product and Service Introduction of Bayer Healthcare AG

• Table Company Profile and Development Status of Abbott Laboratories.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories.

• Figure Sales and Growth Rate Analysis of Abbott Laboratories.

• Figure Revenue and Market Share Analysis of Abbott Laboratories.

• Table Product and Service Introduction of Abbott Laboratories.

• Table Company Profile and Development Status of FHoffmann-La Roche Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of FHoffmann-La Roche Ltd

• Figure Sales and Growth Rate Analysis of FHoffmann-La Roche Ltd

• Figure Revenue and Market Share Analysis of FHoffmann-La Roche Ltd

• Table Product and Service Introduction of FHoffmann-La Roche Ltd

• Table Company Profile and Development Status of Eli Lilly and Company

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

• Figure Sales and Growth Rate Analysis of Eli Lilly and Company

• Figure Revenue and Market Share Analysis of Eli Lilly and Company

• Table Product and Service Introduction of Eli Lilly and Company

• Table Company Profile and Development Status of OXiGENE, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of OXiGENE, Inc.

• Figure Sales and Growth Rate Analysis of OXiGENE, Inc.

• Figure Revenue and Market Share Analysis of OXiGENE, Inc.

• Table Product and Service Introduction of OXiGENE, Inc.

• Table Company Profile and Development Status of F.Hoffmann-La Roche Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of F.Hoffmann-La Roche Ltd

• Figure Sales and Growth Rate Analysis of F.Hoffmann-La Roche Ltd

• Figure Revenue and Market Share Analysis of F.Hoffmann-La Roche Ltd

• Table Product and Service Introduction of F.Hoffmann-La Roche Ltd

• Table Company Profile and Development Status of Merck & Co, Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc

• Figure Sales and Growth Rate Analysis of Merck & Co, Inc

• Figure Revenue and Market Share Analysis of Merck & Co, Inc

• Table Product and Service Introduction of Merck & Co, Inc

• Table Company Profile and Development Status of Silence Therapeutics plc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics plc

• Figure Sales and Growth Rate Analysis of Silence Therapeutics plc

• Figure Revenue and Market Share Analysis of Silence Therapeutics plc

• Table Product and Service Introduction of Silence Therapeutics plc

• Table Company Profile and Development Status of Astrazeneca plc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca plc

• Figure Sales and Growth Rate Analysis of Astrazeneca plc

• Figure Revenue and Market Share Analysis of Astrazeneca plc

• Table Product and Service Introduction of Astrazeneca plc

• Table Company Profile and Development Status of Chugai Pharmaceutical Co, Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chugai Pharmaceutical Co, Ltd

• Figure Sales and Growth Rate Analysis of Chugai Pharmaceutical Co, Ltd

• Figure Revenue and Market Share Analysis of Chugai Pharmaceutical Co, Ltd

• Table Product and Service Introduction of Chugai Pharmaceutical Co, Ltd

• Table Company Profile and Development Status of Celgene Corporation.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation.

• Figure Sales and Growth Rate Analysis of Celgene Corporation.

• Figure Revenue and Market Share Analysis of Celgene Corporation.

• Table Product and Service Introduction of Celgene Corporation.

• Table Company Profile and Development Status of Antisoma plc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antisoma plc

• Figure Sales and Growth Rate Analysis of Antisoma plc

• Figure Revenue and Market Share Analysis of Antisoma plc

• Table Product and Service Introduction of Antisoma plc

• Table Company Profile and Development Status of Merck KGaA

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

• Figure Sales and Growth Rate Analysis of Merck KGaA

• Figure Revenue and Market Share Analysis of Merck KGaA

• Table Product and Service Introduction of Merck KGaA

• Table Company Profile and Development Status of Alcon, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alcon, Inc.

• Figure Sales and Growth Rate Analysis of Alcon, Inc.

• Figure Revenue and Market Share Analysis of Alcon, Inc.

• Table Product and Service Introduction of Alcon, Inc.